Results 71 to 80 of about 7,257 (168)

Determining the potential of desmoglein 3 as a sensitive and specific immunohistochemical marker for the detection of micrometastasis in patients with primary oral squamous cell carcinoma

Contemporary Oncology, 2016
Aim of the study : Despite advances in surgical and radiotherapy techniques, the presence of lymph node metastasis drastically decreases the survival rate of patients with primary oral squamous cell carcinoma (OSCC).
Shruti Nagvekar, Anita Spadigam, Anita Dhupar   +2 more
doaj   +1 more source

2504

Journal of Clinical and Translational Science, 2017
OBJECTIVES/SPECIFIC AIMS: Pemphigus vulgaris (PV) is a potentially fatal blistering disease caused by autoantibodies to the keratinocyte adhesion protein desmoglein 3.
Nina Ran, Christoph Ellebrecht, Eun Jung Choi, Aimee Payne   +3 more
doaj   +1 more source

Elevated desmoglein‐2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on high‐risk cytogenetics and a distinct gene expression profile

British Journal of Haematology, Volume 209, Issue 1, Page 306-310, July 2026.
Barbara J. McClure, John Toubia, Charlotte E. J. Toomes, O. Giles Best, Angelina Yong, Cindy H. Lee, Claudine S. Bonder, Chung Hoow Kok   +7 more
wiley   +1 more source

Comparative Transcriptome Analysis Identifies Desmoglein-3 as a Potential Oncogene in Oral Cancer Cells. [PDF]

Cells, 2023
Wan H, Teh MT, Mastroianni G, Ahmad US.
europepmc   +1 more source

T cell autoimmunity and immune regulation to desmoglein 3, a pemphigus autoantigen. [PDF]

J Dermatol, 2023
Takahashi H, Iriki H, Asahina Y.
europepmc   +1 more source

Circulating Antibodies Against DSG1 and DSG3 in Patients with Oral Lichen Planus: A Scoping Review

Antibodies
Oral Lichen Planus (OLP) is a chronic autoimmune disease with potential overlap with Pemphigus Vulgaris (PV), particularly in erosive forms. Desmoglein 1 and 3 are transmembrane glycoproteins of desmosomes, typically involved in PV.
Domenico De Falco, Francesca Iaquinta, Doriana Pedone, Alberta Lucchese, Dario Di Stasio, Massimo Petruzzi   +5 more
doaj   +1 more source

Attenuation of OX40 signaling suppression by age disrupts peripheral deletion of CD4⁺ T cells specific for the epidermal autoantigen desmoglein 3. [PDF]

Immun Ageing, 2023
Iriki H, Mukai M, Asahina Y, Kubo Y, Ito H, Amagai M, Takahashi H.   +6 more
europepmc   +1 more source

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris. [PDF]

Acta Derm Venereol, 2022
Boch K, Langan EA, Van Beek N, Kridin K, Schmidt E, Zillikens D, Ludwig RJ, Hammers CM, Bieber K.   +8 more
europepmc   +1 more source

Rilzabrutinib-induced transition from pemphigus vulgaris to pemphigus foliaceous: case report and review of the literature

Dermatology Reports
The discovery of the role of Bruton’s Tyrosine Kinase (BTK) in inflammation and autoimmunity has recently led to the development of BTK inhibitors for the treatment of autoimmune diseases, including pemphigus vulgaris.
Christian Ciolfi, Jacopo Tartaglia, Francesca Pampaloni, Laura Fagotto, Andrea Sechi, Mauro Alaibac   +5 more
doaj  

Desmoglein-3 induces YAP phosphorylation and inactivation during collective migration of oral carcinoma cells. [PDF]

Mol Oncol, 2022
Ahmad US, Parkinson EK, Wan H.
europepmc   +1 more source